Bayer discusses relevant clinical study results

October 2, 2020

Video

Patrick Bussfeld, MD, VP, head medical affairs ophthalmology at Bayer Consumer Care AG, discusses the results from several treat-and-extend studies on aflibercept, and how Bayer is participating in the 2020 EURETINA virtual meeting.

See more EURETINA coverage here

Recent Videos

WIO 2024: An educator's perspective on shattering glass ceilings in ophthalmology

Hannah Chiu, MD, FRCSC, highlights some of the early benefits of an AI-operated telephone call system for postoperative patient care at WIO 2024

Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally

ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777